Reuters logo
BRIEF-Progenics Pharmaceuticals Q3 loss per share $0.22
2017年11月2日 / 下午1点15分 / 20 天前

BRIEF-Progenics Pharmaceuticals Q3 loss per share $0.22

Nov 2 (Reuters) - Progenics Pharmaceuticals Inc

* Progenics Pharmaceuticals announces third quarter 2017 financial results and business update

* Q3 loss per share $0.22

* Q3 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S

* Progenics Pharmaceuticals Inc - ‍Q3 revenue totaled $2.7 million, down from $53.9 million in Q3 of 2016​

* Progenics - ‍ended Q3 with cash and cash equivalents of $98.3 million, decrease of $40.6 million versus cash and cash equivalents as of December 31, 2016​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below